These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7568431)

  • 21. Renin secretion in conscious Lyon hypertensive rats.
    Bertolino S; Julien C; Medeiros IA; Cuisinaud G; Vincent M; Barrès C
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1199-204. PubMed ID: 8945954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats.
    Widdop RE; Gardiner SM; Kemp PA; Bennett T
    Br J Pharmacol; 1993 Mar; 108(3):684-8. PubMed ID: 8467356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
    Cassis LA; Rippetoe PE; Soltis EE; Painter DJ; Fitz R; Gillespie MN
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1168-72. PubMed ID: 1527721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
    Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):747-52. PubMed ID: 8113986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of losartan, an AT1 selective angiotensin II receptor antagonist, on isoproterenol-induced cardiac ornithine decarboxylase activity.
    Nakano M; Kanda T; Matsuzaki S; Hasegawa S; Ma H; Imai S; Suzuki T; Kobayashi I
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):21-30. PubMed ID: 7620835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.
    Picard P; Chrétien L; Couture R
    Br J Pharmacol; 1995 Apr; 114(8):1563-70. PubMed ID: 7541280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL; Zhao X; Sun X; Hedner T
    J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
    Foucart S; Patrick SK; Oster L; de Champlain J
    Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M; Freel RW; Shahinfar S; Vaziri ND
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries.
    Kauffman RF; Bean JS; Zimmerman KM; Brown RF; Steinberg MI
    Life Sci; 1991; 49(25):PL223-8. PubMed ID: 1745100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
    Mizuno K; Tani M; Hashimoto S; Niimura S; Sanada H; Watanabe H; Ohtsuki M; Fukuchi S
    Life Sci; 1992; 51(5):367-74. PubMed ID: 1385640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of angiotensin II AT1- or AT2-receptor antagonists on drinking evoked by angiotensin II or water deprivation in rats.
    Widdop RE; Gardiner SM; Bennett T
    Brain Res; 1994 Jun; 648(1):46-52. PubMed ID: 7922526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The angiotensin II subtype 2 (AT2) receptor is linked to protein kinase C but not cAMP-dependent pathways in the cardiomyocyte.
    Rabkin SW
    Can J Physiol Pharmacol; 1996 Feb; 74(2):125-31. PubMed ID: 8723023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
    Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Losartan prevents salt-induced hypertension in reduced renal mass rats.
    Kanagy NL; Fink GD
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1131-6. PubMed ID: 8509998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of angiotensin in the dipsogenic effect of bradykinin in rats.
    Rowland NE; Fregly MJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):699-705. PubMed ID: 9258997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier.
    Bui JD; Kimura B; Phillips MI
    Eur J Pharmacol; 1992 Aug; 219(1):147-51. PubMed ID: 1397042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of Fos in rat brain resulting from endogenously-generated angiotensin II.
    Oldfield BJ; McKinley MJ
    Kidney Int; 1994 Dec; 46(6):1567-9. PubMed ID: 7700008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.